These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 24448752)

  • 1. Additional value of B-type natriuretic peptide on discrimination of patients at risk for mortality after a non-ST-segment elevation acute coronary syndrome.
    García-Alvarez A; Regueiro A; Hernández J; Kasa G; Sitges M; Bosch X; Heras M
    Eur Heart J Acute Cardiovasc Care; 2014 Jun; 3(2):132-40. PubMed ID: 24448752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between plasma N-terminal pro-brain natriuretic peptide and GRACE risk stratification in non-ST-segment elevation acute coronary syndrome].
    Liu WX; Zhao H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):373-7. PubMed ID: 22883085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes: added value on top of GRACE risk score.
    Timóteo AT; Papoila AL; Rio P; Miranda F; Ferreira ML; Ferreira RC
    Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):257-63. PubMed ID: 24687188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
    Bassan R; Tura BR; Maisel AS
    Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 as a predictor of cardiovascular events in troponin-negative non-ST elevation acute coronary syndrome patients.
    García-Salas JM; Tello-Montoliu A; Manzano-Fernández S; Casas-Pina T; López-Cuenca A; Pérez-Berbel P; Puche-Morenilla C; Martínez-Hernández P; Valdés M; Marín F
    Int J Clin Pract; 2014 Mar; 68(3):294-303. PubMed ID: 24372920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes.
    Atwater BD; Milford-Beland S; Newby LK; Hernandez AF; Peacock WF; Gibler WB; Christenson RH; Ohman EM; Peterson ED; Roe MT
    Am J Cardiol; 2007 Dec; 100(12):1727-33. PubMed ID: 18082516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of point of care B-type natriuretic peptide testing and GRACE score in patients with acute coronary syndrome].
    Sun YH; Wang GL; Fu YY; Xue C; Hu DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):716-20. PubMed ID: 20021924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
    Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort study.
    Helanova K; Littnerova S; Kubena P; Ganovska E; Pavlusova M; Kubkova L; Jarkovsky J; Pavkova Goldbergova M; Lipkova J; Gottwaldova J; Kala P; Toman O; Dastych M; Spinar J; Parenica J
    BMJ Open; 2015 Oct; 5(10):e006872. PubMed ID: 26438132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome.
    Bassan F; Bassan R; Esporcatte R; Santos B; Tura B
    Arq Bras Cardiol; 2016 Mar; 106(3):218-25. PubMed ID: 26840056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
    Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
    Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaemia to predict outcome in patients with acute coronary syndromes.
    Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
    Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of B-type natriuretic peptide in the mortality of patients with acute coronary syndrome.
    Scotti AV; Tura BR; Rocha RG; Albuquerque DC
    Arq Bras Cardiol; 2012 Jul; 99(1):605-12. PubMed ID: 22641392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain.
    Haaf P; Reichlin T; Corson N; Twerenbold R; Reiter M; Steuer S; Bassetti S; Winkler K; Stelzig C; Heinisch C; Drexler B; Freidank H; Mueller C
    Am J Med; 2011 May; 124(5):444-52. PubMed ID: 21531234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide and risk of acute kidney injury in patients hospitalized with acute coronary syndromes*.
    Moltrasio M; Cabiati A; Milazzo V; Rubino M; De Metrio M; Discacciati A; Rumi P; Marana I; Marenzi G
    Crit Care Med; 2014 Mar; 42(3):619-24. PubMed ID: 24231760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.